3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol has been researched along with paclitaxel in 1 studies
Studies (3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol) | Trials (3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol) | Recent Studies (post-2010) (3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
117 | 4 | 32 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Son, K | 1 |
1 other study(ies) available for 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and paclitaxel
Article | Year |
---|---|
Factors influencing the drug sensitization of human tumor cells for in situ lipofection.
Topics: Animals; Antineoplastic Agents; Bleomycin; Cation Exchange Resins; Chloramphenicol O-Acetyltransferase; Cholesterol; Cisplatin; DNA; Female; Head and Neck Neoplasms; Lipids; Liposomes; Lung Neoplasms; Mechlorethamine; Mice; Mice, SCID; Ovarian Neoplasms; Paclitaxel; Phosphatidylethanolamines; Transfection | 1996 |